Cover Image
Market Research Report
Product code
933037

North America Cell Expansion Market to 2027 - Regional Analysis and Forecasts by Product, Cell Type, Application, End User, and Country

Published: | The Insight Partners | 165 Pages | Delivery time: 1-2 business days

Price

Back to Top
North America Cell Expansion Market to 2027 - Regional Analysis and Forecasts by Product, Cell Type, Application, End User, and Country
Published: March 9, 2020
The Insight Partners
Content info: 165 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The cell expansion market in North America is anticipated to reach USD 14,697.41 million by 2027 from USD 4,522.07 4 million in 2019; it is projected to grow at a CAGR of 15.9% during 2020-2027. The growth of the market is attributed to the increasing prevalence of cancer, rising number of new product launches, and increasing inclination of patients toward regenerative and personalized medicines. Also, growing R&D expenditure on cancer research is likely to have a positive impact on the growth of the market in the coming years. In addition, technological advancements in the pharmaceuticals industry and extensive developments in drug discovery are likely to stimulate the growth of cell expansion market in North America during the forecast period.

Cell expansion is the large-scale artificial production of daughter cells from a single cell, and the process is carried out to support the medical research. It plays a critical role in exploring a wider range of benefits and applications of fully differentiated stem cell cultures for their use in therapeutics, drug screening, or advanced research.

R&D is a significant part of a majority of pharmaceutical and biotech companies; they focus on R&D to come up with new molecules with the most significant medical and commercial potential for various therapeutic applications. The companies invest big amounts in these activities to deliver innovative, high-quality products to the market. Moreover, as per the report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expense of biopharmaceutical companies surged from US$ 49.6 billion in 2012 to US$ 58.8 billion in 2015. Several government organizations are working on enhancing the detection methods and treatment procedures of cancer in the region. The National Cancer Institute (NCI) spends on various categories of the treatment, including specific cancer sites, cancer types, and cancer-related diseases, as well as types of NCI research mechanisms. The NCI allocated the funds of ~US$ 208.4 million for cell expansion research in 2017 from their total budget of US$ 5,636.4 million in that year for cancer research studies. Therefore, the growing R&D expenditure on cancer research by these companies is expected to provide them with opportunities for business expansion.

The North American cell expansion market has been segmented on the basis of cell type into human cells and animal cells. The human cells segment held a larger share of the market in 2018, and it is also projected to register a higher CAGR in it during the forecast period. Rise in research activities for the treatment of cancer is expected to offer considerable growth opportunities for the human cell expansion market players.

A few of the important secondary sources referred to for preparing this report on the cell expansion market are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), and American Cancer Society.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cell expansion market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America cell expansion market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00009520

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Cell Expansion Market - By Product
    • 1.3.2 North America Cell Expansion Market - By Cell Type
    • 1.3.3 North America Cell Expansion Market - By Application
    • 1.3.4 North America Cell Expansion Market - By End User
    • 1.3.5 North America Cell Expansion Market - By Country

2. North America Cell Expansion Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Cell Expansion Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Expansion Market - North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Cell Expansion Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Patient shift towards regenerative medicines
    • 5.1.2 Increasing number of patients suffering with cancer
  • 5.2 Key Restraints
    • 5.2.1 Risk of contamination associated with the cell expansion process
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing R&D Expenditure for Cancer Research
  • 5.4 Future Trend
    • 5.4.1 Extensive development in drug discovery
  • 5.5 Impact Analysis

6. Cell Expansion Market - North America Analysis

  • 6.1 North America Cell Expansion Market Revenue Forecasts and Analysis
  • 6.2 Positioning Of Key Players

7. North America Cell Expansion Market Analysis And Forecasts To 2027 - Product

  • 7.1 Overview
  • 7.2 North America Cell Expansion Market, By Product 2018 & 2027 (%)
    • 7.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Product (US$ Mn)
      • 7.2.1.1 North America Consumables Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 7.2.1.1.1 North America Disposables Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 7.2.1.2 North America Instruments Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • 7.3 Consumables
    • 7.3.1 Overview
    • 7.3.2 North America Consumables Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 Reagents, Media & Serum
      • 7.3.3.1 Overview
      • 7.3.3.2 North America Reagents, Media & Serum Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Disposables
      • 7.3.4.1 Overview
      • 7.3.4.2 North America Disposables Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.3.4.3 Culture Tissue Flasks
        • 7.3.4.3.1 Overview
        • 7.3.4.3.2 North America Culture Tissue Flasks Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.3.4.4 Bioreactor Accessories
        • 7.3.4.4.1 Overview
        • 7.3.4.4.2 North America Bioreactor Accessories Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.3.4.5 Other Disposables
        • 7.3.4.5.1 Overview
        • 7.3.4.5.2 North America Other Disposables Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 North America Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Cell Expansion Supporting Equipment
      • 7.4.3.1 Overview
      • 7.4.3.2 North America Cell Expansion Supporting Equipment Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Bioreactors
      • 7.4.4.1 Overview
      • 7.4.4.2 North America Bioreactors Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.5 Automated Cell Expansion Systems
      • 7.4.5.1 North America Automated Cell Expansion Systems Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Cell Expansion Market Analysis And Forecasts To 2027 - Cell Type

  • 8.1 Overview
  • 8.2 North America Cell Expansion Market, By Cell Type 2018 & 2027 (%)
    • 8.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Cell Type (US$ Mn)
  • 8.3 Human Cells
    • 8.3.1 Overview
    • 8.3.2 North America Human Cells Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.3.3 Adult Stem Cells
      • 8.3.3.1 Overview
      • 8.3.3.2 North America Adult Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.3.4 Induced Pluripotent Stem Cells
      • 8.3.4.1 Overview
      • 8.3.4.2 North America Induced Pluripotent Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.3.5 Embryonic Stem Cells
      • 8.3.5.1 Overview
      • 8.3.5.2 North America Embryonic Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)
    • 8.3.6 Differentiated Cells
      • 8.3.6.1 Overview
      • 8.3.6.2 North America Differentiated Cells Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Animal Cells
    • 8.4.1 Overview
    • 8.4.2 North America Animal Cells Market Revenue and Forecast to 2027 (US$ Mn)

9. North America Cell Expansion Market Analysis- By Application

  • 9.1 Overview
  • 9.2 North America Cell Expansion Market, By Application 2018 & 2027 (%)
    • 9.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Application (US$ Mn)
  • 9.3 Regenerative Medicine and Stem Cell Research
    • 9.3.1 Overview
    • 9.3.2 North America Regenerative Medicine and Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.4 Cancer and Cell-based Research
    • 9.4.1 Overview
    • 9.4.2 North America Cancer and Cell-based Research Market Revenue and Forecasts to 2027 (US$ Mn)
  • 9.5 Other Applications
    • 9.5.1 Overview
    • 9.5.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

10. North America Cell Expansion Market Analysis- By End User

  • 10.1 Overview
  • 10.2 North America Cell Expansion Market, By End User 2018 & 2027 (%)
    • 10.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 10.3 Biopharmaceutical And Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 North America Biopharmaceutical And Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.4 Research Institutes
    • 10.4.1 Overview
    • 10.4.2 North America Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.5 Cell Banks
    • 10.5.1 Overview
    • 10.5.2 North America Cell Banks Market Revenue and Forecasts to 2027 (US$ Mn)
  • 10.6 Other End Users
    • 10.6.1 Overview
    • 10.6.2 North America Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

11. Cell Expansion Market Revenue And Forecasts To 2027 - Geographical Analysis

  • 11.1 North America Cell Expansion Market, Revenue and Forecast to 2027
    • 11.1.1 North America Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
    • 11.1.2 North America Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 11.1.2.1 North America Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.2.1.1 North America Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 11.1.2.2 North America Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.3 North America Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
      • 11.1.3.1 North America Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.4 North America Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 11.1.5 North America Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
    • 11.1.6 North America Cell Expansion Market, Revenue and Forecast to 2027, By Country (%)
    • 11.1.7 US
      • 11.1.7.1 US Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
      • 11.1.7.2 US Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
        • 11.1.7.2.1 US Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.7.2.1.1 US Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.7.2.2 US Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.8 US Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
      • 11.1.8.1 US Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.9 US Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 11.1.10 US Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
    • 11.1.11 Canada
      • 11.1.11.1 Canada Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
      • 11.1.11.2 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
        • 11.1.11.2.1 Canada Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.11.2.1.1 Canada Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.11.2.2 Canada Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.12 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
      • 11.1.12.1 Canada Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.13 Canada Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 11.1.14 Canada Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)
    • 11.1.15 Mexico
      • 11.1.15.1 Mexico Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)
      • 11.1.15.2 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)
        • 11.1.15.2.1 Mexico Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.15.2.1.1 Mexico Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)
        • 11.1.15.2.2 Mexico Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.16 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)
      • 11.1.16.1 Mexico Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 11.1.17 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 11.1.18 Mexico Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)

12. North America Cell Expansion Market- Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies In The Cell Expansion Market, 2017-2019
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
      • 12.3.1.1 Recent Organic Developments By Players In The Cell Expansion Market
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview
    • 12.4.2 Recent Developments By Players In The Cell Expansion Market

13. Global Cell Expansion Market-Key Company Profiles

  • 13.1 BD
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Financial Overview
    • 13.1.4 Product Portfolio
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Merck KGaA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Financial Overview
    • 13.2.4 Product Portfolio
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Financial Information
    • 13.3.4 Product /Services Portfolio
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Terumo Corporation
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Financial Overview
    • 13.4.4 Product portfolio
    • 13.4.5 SWOT ANALYSIS
    • 13.4.6 Key Developments
  • 13.5 General Electric Company
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Financial Overview
    • 13.5.4 Product Portfolio
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Corning Incorporated
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Financial Overview
    • 13.6.4 Product Portfolio
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Miltenyi Biotec
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Financial Overview
    • 13.7.4 Product Portfolio
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Danaher
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Financial Information
    • 13.8.4 Product Portfolio
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Lonza
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Financial Information
    • 13.9.4 Product Portfolio
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 STEMCELL Technologies, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Information
    • 13.10.4 Product Portfolio
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Cell Expansion Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 2. North America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 3. North America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 4. North America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 5. North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 6. North America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 7. North America Cell Expansion Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 8. North America Cell Expansion Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 9. North America Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 10. North America Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 11. North America Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 12. North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 13. North America Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 14. North America Cell Expansion Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 15. US Cell Expansion Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 16. US Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 17. US Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 18. US Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 19. US Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 20. US Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 21. US Cell Expansion Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 22. Canada Cell Expansion Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 23. Canada Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 24. Canada Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 25. Canada Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 26. Canada Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 27. Canada Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 28. Canada Cell Expansion Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 29. Mexico Cell Expansion Market Revenue and Forecasts To 2027, By Product (US$ Mn)
  • Table 30. Mexico Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 31. Mexico Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 32. Mexico Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 33. Mexico Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 34. Mexico Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 35. Mexico Cell Expansion Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 36. Recent Organic Growth Strategies In The Cell Expansion Market
  • Table 37. Recent Inorganic Growth Strategies In The Cell Expansion Market
  • Table 38. Glossary of Terms, Cell Expansion Market

LIST OF FIGURES

  • Figure 1. Cell Expansion Market Segmentation
  • Figure 2. North America Cell Expansion Market Overview
  • Figure 3. Diagnosis Type Segment Held Largest Share Of Product Segment In Cell Expansion Market
  • Figure 4. US Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 5. North America cell expansion Market- Leading Country Markets (US$ Mn)
  • Figure 6. North America cell expansion Market, Industry Landscape
  • Figure 7. Cell Expansion Market - North America PEST Analysis
  • Figure 8. Comparison of Brand - Name Drugs and Generic Drugs
  • Figure 9. Cell Expansion Market Impact Analysis of Drivers And Restraints
  • Figure 10. North America Cell Expansion Market - Revenue Forecasts and Analysis - 2018- 2027
  • Figure 11. Market Positioning Of Key Player In North America Cell Expansion Market
  • Figure 12. North America Cell Expansion Market, by Product 2018 & 2027 (%)
  • Figure 13. North America Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. North America Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 15. North America Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 16. North America Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 17. North America Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 18. North America CEA Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 19. North America Other Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 20. North America Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. North America Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 22. North America Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 23. North America Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 24. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 25. North America Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 26. North America Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 27. North America Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 28. North America Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 29. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 30. North America Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 31. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 32. North America Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. North America Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 34. North America Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 35. North America Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 36. North America Cell Expansion Market, by End User 2018 & 2027 (%)
  • Figure 37. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. North America Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. North America Cell Expansion Market Revenue Overview, By Country (2018) (US$ Mn)
  • Figure 40. North America Cell Expansion Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. North America Cell Expansion Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 42. US Cell Expansion Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. Canada Cell Expansion Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. Mexico Cell Expansion Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Growth Strategies In The Cell Expansion Market, 2016-2019